D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.63B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SPCX
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Rocket Companies
RKT
$39.6B
| $5.42M | ﹤0.01% |
344,151
-1,469,026
| -81% | -$21.2M |
|
2227
Clarivate
CLVT
$1.23B
| $5.42M | ﹤0.01% |
2,508,854
+183,428
| +8% | +$448K |
|
2228
CALL
Blackstone
BX
$102B
| $5.41M | ﹤0.01% |
46,000
+20,300
| +79% | +$2.44M |
|
|
ORC
2229
Orchid Island Capital
ORC
$1.32B
| $5.41M | ﹤0.01% |
775,558
-662,946
| -46% | -$4.57M |
|
2230
Phreesia
PHR
$635M
| $5.4M | ﹤0.01% |
524,496
+512,955
| +4,445% | +$4.76M |
|
2231
AtriCure
ATRC
$2.68B
| $5.4M | ﹤0.01% |
192,824
+136,235
| +241% | +$3.83M |
|
2232
CALL
Steel Dynamics
STLD
$34.4B
| $5.39M | ﹤0.01% |
+23,500
| New | +$5.5M |
|
2233
PUT
Vishay Intertechnology
VSH
$4.89B
| $5.38M | ﹤0.01% |
+100,000
| New | +$4.09M |
|
2234
CALL
Lyft
LYFT
$6.14B
| $5.38M | ﹤0.01% |
367,900
-122,800
| -25% | -$1.72M |
|
2235
Installed Building Products
IBP
$6.21B
| $5.37M | ﹤0.01% |
23,381
-22,670
| -49% | -$5.51M |
|
|
FLG
2236
CALL
Flagstar Bank National Association
FLG
$5.61B
| $5.37M | ﹤0.01% |
359,500
-133,000
| -27% | -$1.89M |
|
2237
MYR Group
MYRG
$4.52B
| $5.37M | ﹤0.01% |
10,728
+4,111
| +62% | +$1.69M |
|
2238
Grab
GRAB
$13.6B
| $5.36M | ﹤0.01% |
1,422,754
-2,794,959
| -66% | -$10.2M |
|
|
AADX
2239
Applied Aerospace & Defense Inc
AADX
$2.17B
| $5.35M | ﹤0.01% |
+235,000
| New | +$4.61M |
|
2240
Ferrari
RACE
$71.1B
| $5.35M | ﹤0.01% |
14,372
+13,187
| +1,113% | +$4.59M |
|
2241
United Microelectronic
UMC
$55B
| $5.34M | ﹤0.01% |
196,314
-1,695,294
| -90% | -$29M |
|
|
ABVX
2242
CALL
Abivax
ABVX
$10.2B
| $5.33M | ﹤0.01% |
+40,000
| New | +$4.53M |
|
|
HCAC
2243
Hall Chadwick Acquisition Corp
HCAC
$295M
| $5.32M | ﹤0.01% |
529,906
+500,300
| +1,690% | +$5M |
|
2244
JFrog
FROG
$10.7B
| $5.32M | ﹤0.01% |
+58,506
| New | +$3.8M |
|
|
EMA
2245
CALL
Emera Inc
EMA
$15.6B
| $5.3M | ﹤0.01% |
100,000
+25,000
| +33% | +$1.31M |
|
|
BELFB
2246
PUT
Bel Fuse Inc Class B
BELFB
$3.57B
| $5.3M | ﹤0.01% |
15,900
+14,400
| +960% | +$3.89M |
|
2247
CALL
Sprouts Farmers Market
SFM
$7.26B
| $5.29M | ﹤0.01% |
62,500
+16,800
| +37% | +$1.36M |
|
2248
BioMarin Pharmaceuticals
BMRN
$12.7B
| $5.28M | ﹤0.01% |
92,214
-190,246
| -67% | -$10.4M |
|
2249
e.l.f. Beauty
ELF
$6.21B
| $5.27M | ﹤0.01% |
71,185
+62,022
| +677% | +$3.77M |
|
2250
Trevi Therapeutics
TRVI
$2.43B
| $5.26M | ﹤0.01% |
281,996
+100,652
| +56% | +$1.46M |
|
Similar funds
D.E. Shaw & Co's Q2 2026 Portfolio in Review
As of Q2 2026, D.E. Shaw & Co held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
D.E. Shaw & Co deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- D.E. Shaw & Co's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.63B increase.
- D.E. Shaw & Co's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- D.E. Shaw & Co fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- D.E. Shaw & Co's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- D.E. Shaw & Co opened 872 new positions and closed 527 in Q2 2026.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.